Global Nuclear Medicine Market Overview:
Global Nuclear Medicine Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Nuclear Medicine Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Nuclear Medicine involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Nuclear Medicine Market:
The Nuclear Medicine Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Nuclear Medicine Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Nuclear Medicine Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Nuclear Medicine market has been segmented into:
Diagnostics (Single Photon Emission Computed Tomography (SPECT
By Application, Nuclear Medicine market has been segmented into:
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROS
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Nuclear Medicine market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Nuclear Medicine market.
Top Key Players Covered in Nuclear Medicine market are:
GE Healthcare
Curium
Novartis AG (Advanced Accelerator Applications)
Cardinal Health Inc.
LANTHEUS HOLDINGS
INC
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Nuclear Medicine Market Type
4.1 Nuclear Medicine Market Snapshot and Growth Engine
4.2 Nuclear Medicine Market Overview
4.3 Diagnostics (Single Photon Emission Computed Tomography (SPECT
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Diagnostics (Single Photon Emission Computed Tomography (SPECT: Geographic Segmentation Analysis
Chapter 5: Nuclear Medicine Market Application
5.1 Nuclear Medicine Market Snapshot and Growth Engine
5.2 Nuclear Medicine Market Overview
5.3 Pharmaceutical and Biotechnology Companies
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Pharmaceutical and Biotechnology Companies: Geographic Segmentation Analysis
5.4 Contract Research Organizations (CROS
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Contract Research Organizations (CROS: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Nuclear Medicine Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 GE HEALTHCARE
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 CURIUM
6.4 NOVARTIS AG (ADVANCED ACCELERATOR APPLICATIONS)
6.5 CARDINAL HEALTH INC.
6.6 LANTHEUS HOLDINGS
6.7 INC
Chapter 7: Global Nuclear Medicine Market By Region
7.1 Overview
7.2. North America Nuclear Medicine Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Diagnostics (Single Photon Emission Computed Tomography (SPECT
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Pharmaceutical and Biotechnology Companies
7.2.3.2 Contract Research Organizations (CROS
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Nuclear Medicine Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Diagnostics (Single Photon Emission Computed Tomography (SPECT
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Pharmaceutical and Biotechnology Companies
7.3.3.2 Contract Research Organizations (CROS
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Nuclear Medicine Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Diagnostics (Single Photon Emission Computed Tomography (SPECT
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Pharmaceutical and Biotechnology Companies
7.4.3.2 Contract Research Organizations (CROS
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Nuclear Medicine Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Diagnostics (Single Photon Emission Computed Tomography (SPECT
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Pharmaceutical and Biotechnology Companies
7.5.3.2 Contract Research Organizations (CROS
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Nuclear Medicine Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Diagnostics (Single Photon Emission Computed Tomography (SPECT
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Pharmaceutical and Biotechnology Companies
7.6.3.2 Contract Research Organizations (CROS
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Nuclear Medicine Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Diagnostics (Single Photon Emission Computed Tomography (SPECT
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Pharmaceutical and Biotechnology Companies
7.7.3.2 Contract Research Organizations (CROS
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Nuclear Medicine Scope:
|
Report Data
|
Nuclear Medicine Market
|
|
Nuclear Medicine Market Size in 2025
|
USD XX million
|
|
Nuclear Medicine CAGR 2025 - 2032
|
XX%
|
|
Nuclear Medicine Base Year
|
2024
|
|
Nuclear Medicine Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
GE Healthcare, Curium, Novartis AG (Advanced Accelerator Applications), Cardinal Health Inc., LANTHEUS HOLDINGS, INC.
|
|
Key Segments
|
By Type
Diagnostics (Single Photon Emission Computed Tomography (SPECT
By Applications
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROS
|
